Reduced expression of TRF1 is associated with tumor progression and poor prognosis in oral squamous cell carcinoma

Experimental and Therapeutic Medicine

Volumn 2, Issue 1, 2011, Pages 63-67

  Chuang, Hui Ching ^a,d   Chen, Chang Han ^a,d,e   Huang, Chao Cheng ^b,d   Fang, Fu Min ^c,d   Tsai, Hsin Ting ^a,d   Chien, Chih Yen ^a,d  

^a Departments of Otolaryngology   (Japan)

^b Departments of Pathology   (Finland)

^c Departments of Radiation Oncology   (Jordan)

^d Cancer Center   (Taiwan)

^e CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Oral cavity squamous cell carcinoma; Telomeric repeat binding factor 1; Telomeric repeat binding factor 2

Indexed keywords

TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 2;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MOUTH SQUAMOUS CELL CARCINOMA; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

EID: 78751620800     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2010.168     Document Type: Article

References (32)

1. Shah JP and Singh B: Why the lack of progress for oral cancer? Lancet Oncol 7: 356-357, 2006.
2. Chien CY, Su CY, Chuang HC, et al: Angiopoietin-1 and -2 expression in recurrent squamous cell carcinoma of the oral cavity. J Surg Oncol 97: 273-277, 2008.
3. Chen PH, Ko YC, Yang YH, et al: Important prognostic factors of long-term oropharyngeal carcinoma survivors in Taiwan. Oral Oncol 40: 847-855, 2004.
4. Matsuo JM, Patel SG, Singh B, et al: Clinical nodal stage is an independently significant predictor of distant failure in patients with squamous cell carcinoma of the larynx. Ann Surg 238: 412-421, 2003.
5. Chien CY, Su CY, Chuang HC, et al: Comprehensive study on the prognostic role of osteopontin expression in oral squamous cell carcinoma. Oral Oncol 45: 798-802, 2009.
6. Chen CH, Chien CY, Huang CC, et al: Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity. Oncogene 28: 2723-2737, 2009.
7. Vaziri H, Schachter F, Uchida I, et al: Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 52: 661-667, 1993.
8. Van Steensel B and de Lange T: Control of telomere length by the human telomeric protein TRF1. Nature 385: 740-743, 1997.
9. Smogorzewska A, van Steensel B, Bianchi A, et al: Control of human telomere length by TRF1 and TRF2. Mol Cell Biol 20: 1659-1668, 2000.
10. Sfeir A, Kosiyatrakul ST, Hockemeyer D, et al: Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell 138: 90-103, 2009.
11. Van Steensel B, Smogorzewska A and de Lange T: TRF2 protects human telomeres from end-to-end fusions. Cell 92: 401-413, 1998.
12. Ancelin K, Brunori M, Bauwens S, et al: Targeting assay to study the cis functions of human telomeric proteins: evidence for inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2. Mol Cell Biol 22: 3474-3487, 2002.
13. Yamada K, Yagihashi A, Yamada M, et al: Decreased gene expression for telomeric-repeat binding factors and TIN2 in malignant hematopoietic cells. Anticancer Res 22: 1315-1320, 2002.
14. Yamada M, Tsuji N, Nakamura M, et al: Down-regulation of TRF1, TRF2 and TIN2 genes is important to maintain telomeric DNA for gastric cancers. Anticancer Res 22: 3303-3307, 2002.
15. Miyachi K, Fujita M, Tanaka N, Sasaki K and Sunagawa M: Correlation between telomerase activity and telomeric-repeat binding factors in gastric cancer. J Exp Clin Cancer Res 21: 269-275, 2002.
16. Lin X, Gu J, Lu C, Spitz MR and Wu X: Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer. Clin Cancer Res 12: 5720-5725, 2006.
17. Raynaud CM, Jang SJ, Nuciforo P, et al: Telomere shortening is correlated with the DNAdamage response and telomeric protein down-regulation in colorectal preneoplastic lesions. Ann Oncol 19: 1875-1881, 2008.
18. Frias C, Garcia-Aranda C, De Juan C, et al: Telomere shortening is associated with poor prognosis and telomerase activity correlates with DNA repair impairment in non-small cell lung cancer. Lung Cancer 60: 416-425, 2008.
19. d'Adda di Fagagna F, Reaper PM, ClayFarrace L, et al.: A DNA damage checkpoint response in telomere-initiated senescence. Nature 426: 194-198, 2003.
20. Yajima T, Yagihashi A, Kameshima H, Kobayashi D, Hirata K and Watanabe N: Telomerase reverse transcriptase and telomeric-repeat binding factor protein 1 as regulators of telomerase activity in pancreatic cancer cells. Br J Cancer 85: 752-757, 2001.
21. Salhab M, Jiang WG, Newbold RF and Mokbel K: The expression of gene transcripts of telomere-associated genes in human breast cancer: correlation with clinico-pathological parameters and clinical outcome. Breast Cancer Res Treat 109: 35-46, 2008.
22. Feldser DM, Hackett JA and Greider CW. Telomere dysfunction and the initiation of genome instability. Nat Rev Cancer 3: 623-627, 2003.
23. Chong L, van Steensel B, Broccoli D, et al: Ahuman telomeric protein. Science 270: 1663-1667, 1995.
24. Broccoli D, Smogorzewska A, Chong Land de Lange T.: Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat Genet 17: 231-235, 1997.
25. Saito K, Yagihashi A, Nasu S, Izawa Y, et al: Gene expression for suppressors of telomerase activity (telomeric-repeat binding factors) in breast cancer. Jpn J Cancer Res 93: 253-258, 2002.
26. Yamada K, Yajima T, Yagihashi A, et al: Role of human telomerase reverse transcriptase and telomeric-repeat binding factor proteins 1 and 2 in human hematopoietic cells. Jpn J Cancer Res 91: 1278-1284, 2000.
27. La Torre D, de Divitiis O, Conti A, et al: Expression of telomeric repeat binding factor-1 in astroglial brain tumors. Neurosurgery 56: 802-810, 2005.
28. Kishi S, Wulf G, Nakamura Mand Lu KP: Telomeric protein Pin2/TRF1 induces mitotic entry and apoptosis in cells with short telomeres and is down-regulated in human breast tumors. Oncogene 20: 1497-1508, 2001.
29. Oh BK, Kim YJ, Park C and Park YN: Up-regulation of telomere-binding proteins, TRF1, TRF2, and TIN2 is related to telomere shortening during human multi step hepatocarcinogenesis. Am J Pathol 166: 73-80, 2005.
30. Klapper W, Qian W, Schulte Cand Parwaresch R: DNA damage transiently increases TRF2 mRNA expression and telomerase activity. Leukemia 17: 2007-2015, 2003.
31. Klapper W, Krams M, Qian W, Janssen D and Parwaresch R: Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTER Ttranscription and correlated with telomere-binding protein expression but uncoupled from proliferation. Br J Cancer 89: 713-719, 2003.
32. Nakanishi K, Kawai T, Kumaki F, et al: Expression of mRNAs for telomeric repeat binding factor (TRF)-1 and TRF2 in atypical adenomatous hyperplasia and adenocarcinoma of the lung. Clin Cancer Res 9: 1105-1111, 2003.